Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group
Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group
Languages of Item:
English
Abstract:
Empty abstract
Publication year:
2014
Authors:
Karavasilis, Vasilios Kosmidis, Paris Syrigos, Konstantinos N Mavropoulou, Polyxeni Dimopoulos, Meletios A Kotoula, Vassiliki Pectasides, Dimitrios Boukovinas, Ioannis Klouvas, George Kalogera-Fountzila, Anna others
